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OBJECTIVE — To investigate changes in the foot muscle energy reserves in diabetic non-
neuropathic and neuropathic patients.
RESEARCH DESIGN AND METHODS — We measured the phosphocreatinine (PCr)/
inorganic phosphate (Pi) ratio, total
31P concentration, and the lipid/water ratio in the muscles
in the metatarsal head region using MRI spectroscopy in healthy control subjects and non-
neuropathic and neuropathic diabetic patients.
RESULTS — ThePCr/Piratiowashigherinthecontrolsubjects(3.230.43)followedbythe
non-neuropathic group (2.61  0.36), whereas it was lowest in the neuropathic group (0.60 
1.02) (P  0.0001). There were no differences in total
31P concentration and lipid/water ratio
between the control and non-neuropathic groups, but both measurements were different in the
neuropathic group (P  0.0001).
CONCLUSIONS — Restingfootmuscleenergyreservesareaffectedbeforethedevelopment
of peripheral diabetic neuropathy and are associated with the endothelial dysfunction and
inﬂammation.
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F
oot muscles undergo atrophy in the
presence of diabetic neuropathy
leading to prominent metatarsal
heads and the development of the so-
called“minorfoot”(1).However,littlein-
formation is available regarding the
function of the foot muscles, especially in
the absence of peripheral neuropathy.
Magnetic resonance imaging (MRI) mea-
surements of phosphorus (
31P) metabo-
lites can evaluate the muscle energy
reserves and provide valuable informa-
tion regarding the muscle function (2).
Phosphocreatinine (PCr) is the energy
reservoirthatmaintainstheconcentration
of adenosine triphosphate (ATP) at levels
requiredforcellularfunctionandmainte-
nance, whereas inorganic phosphate (Pi)
is a metabolite produced by the hydroly-
sis of ATP to adenosine diphosphate ADP
(3).Inthesituationwhentheoxygensup-
ply to the muscles is insufﬁcient, such as
intensive exercise in healthy subjects or
tissue ischemia, the PCr/Pi ratio de-
creases. In the present study, we exam-
ined the effect of diabetes and peripheral
neuropathy in the foot muscle energy re-
serves by using a clinical 3-Tesla (3T) MR
scanner with multinuclear imaging capa-
bility and the MRI technique known as
rapid acquisition with relaxation en-
hancement (RARE), which allows the
quantiﬁcation of the
31P cellular metabo-
lites (4). We have also investigated the
association of these changes to changes in
the endothelial function and levels of se-
rumcytokinesthatrelatedtothedevelop-
ment of inﬂammation and vascular
disease.
RESEARCH DESIGN AND
METHODS— We studied 64 subjects
dividedintothreegroupsmatchedforage
and sex: 24 healthy nondiabetic subjects,
22 diabetic subjects with no clinical pe-
ripheral neuropathy, and 18 neuropathic
diabetic subjects. The study protocol was
approved by our institutional review
board. All participants gave written in-
formed consent.
Procedures
Presence of diabetic peripheral neuropa-
thy was determined according to stan-
dard clinical techniques as previously
described (5). Endothelium-dependent
vasodilation in the macro- and microcir-
culation was measured as previously de-
scribed (6).
MRI measurements of phosphorus
(
31P) metabolites
Phosphorus-31 MRI data were acquired
on a GE 3T whole-body MR scanner
(General Electric Medical Systems, Mil-
waukee, WI). A transaxial imaging plane
was prescribed through the metatarsal
headregionofthefoot.Separateimagesof
PCr and Pi cellular metabolites were ac-
quired using a rapid acquisition with re-
laxation enhancement (RARE) pulse
sequence with chemical selectivity capa-
bilities (7). The PCr and Pi images were
acquiredsimultaneouslyinasingle6-min
scan. After the
31P imaging, standard T2-
weighted (T2-W) proton (
1H) spin-echo
MRI was performed to acquire detailed
images of the anatomy. The scan time for
the T2-W 1H images was 6 min and 24 s.
The spatial resolution of the PCr and Pi
images was 0.47  0.47  2.5 cm (voxel
volume  0.55 cm
3) and the T2-W
images 0.06  0.06  0.25 cm (voxel
volume  0.0009 cm
3).
For the measurements of the intra-
muscular lipid and water content, single-
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1H spectra were acquired using the
point resolved spectral selection (PRESS)
techniquewithoutwatersuppression.For
each subject, the PCr and Pi concentra-
tions in the metatarsal head region were
calculated as previously described (8). A
PCr/Pi map was generated by dividing
thePCrimagebythePiimage.Theresult-
ing PCr/Pi map was registered to the
T2-W anatomical images to identify the
muscle beds that had abnormal PCr/Pi
ratios.
Statistical analysis
Statistical analysis was performed in col-
laboration with a biostatistician (C.G.).
For parametrically distributed data, the
ANOVA test was used. The contribution
of cytokines and growth factors in the
variation of MRI measurements was as-
sessed by univariate and multivariate
stepwise regression analysis.
RESULTS— Theclinicalcharacteristic
of the three studied groups are shown in
Table A1 in the online appendix (avail-
able at http://care.diabetesjournals.org/
cgi/content/full/dc09-0536/DC1). The re-
sults of biochemical measurements are
showninTableA2intheonlineappendix.
MRIT1-weightedandPCr/Piimagesfrom
a healthy control subject, a diabetic non-
neuropathic patient, and a neuropathic
patient are shown in the ﬁgure in the on-
line appendix.
The results of the PCr/Pi ratio are
shown in Fig. 1A. There were signiﬁcant
Figure 1—A: Results of the PCr/Pi ratio. Signiﬁcant differences were found among all groups. The PCr/Pi was signiﬁcantly higher in the control
group(C)followedbythenon-neuropathicgroup(DM)andwaslowestintheneuropathicgroup(PDN)(*vs.¶vs.†:P0.0001).B:Resultsofthe
total
31P concentration. The
31P concentration was similar in the control and the non-neuropathic group and lower in the neuropathic group (* vs.
†: P  0.0001). C: Results of the foot lipid/water ratio. The ratio was similar in the control and the non-neuropathic group and lower in the
neuropathic group (* vs. †: P  0.0001).
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higher in the control subjects (3.23 
0.43) followed by the non-neuropathic
group (2.61  0.36), whereas the PCr/Pi
ratio was lowest in the neuropathic group
(0.60  1.02) (P  0.0001). The results
of the total
31P concentration are shown
in Fig. 1B. There were no differences be-
tween the control (28.7  5.4) and non-
neuropathic groups (25.0  5.5), but the
neuropathic group had a lower concen-
tration (6.0  10.5) (P  0.0001). The
lipid/water ratio was also similar in the
control (0.18  0.11) and the non-
neuropathic groups (0.27  0.17) and
higher in the neuropathic group (1.56 
0.52) (P  0.0001) (Fig. 1C).
When all subjects were considered as
one group, signiﬁcant correlations were
found between PCr/Pi ratio and ﬂow-
mediated dilation (FMD) (r  0.51, P 
0.0001),neuropathydisabilityscore(NDS)
(r0.75,P0.0001),vibrationpercep-
tion threshold (r  0.72, P  0.0001),
Semmes Weinstein monoﬁlaments (r 
0.83, P  0.0001), granulocyte colony–
stimulating factor (r  0.29, P  0.05),
platelet-derivedgrowthfactorAA(r0.29,
P  0.05), tumor necrosis factor- (r 
0.30, P  0.05), sE-selectin (r  0.35,
P  0.01), soluble intracellular adhesion
molecule (r 0.36, P0.01), and solu-
ble vascular cell adhesion molecule
(sVCAM) (r  0.40, P  0.01). Border-
linesigniﬁcanceswerefoundinthecorrela-
tions between PCr/Pi ratio and the skin
blood ﬂow at the dorsum of the foot (r 
0.25,P0.059)andvascularendothelial
growth factor (r  0.26, P  0.054). On
stepwise multivariate analysis, NDS, FMD,
and sE-selectin contributed 59, 6, and 5%,
respectively, to the variation of the PCr/Pi
ratio.Thetotal
31Pconcentrationcorrelated
with FMD (r  0.41, P  0.001), NDS
(r0.73,P0.0001),vibrationpercep-
tion threshold (r  0.68, P  0.0001),
Semmes Weinstein monoﬁlaments (r 
0.81, P  0.0001), tumor necrosis fac-
tor- (r  0.30, P  0.05), and soluble
vascular cell adhesion molecule (r 
0.38,P0.05).Onstepwisemultivariate
analysis, NDS, sVCAM, and FMD contrib-
uted56,4,and2%,respectively,tothevari-
ation of the total
31P concentration.
To exclude neuropathy as a con-
founding factor, we performed the same
analysis as above in a separate group that
included the control and non-neuro-
pathic subjects but excluded the diabetic
neuropathic patients. In this analysis, the
PCr/Pi ratio correlated with FMD (r 
0.42, P  0.01) and vascular endothelial
growthfactor(r0.35,P0.05).The
total
31P concentration inversely corre-
lated with the skin blood ﬂow at the dor-
sumofthefoot(r0.39,P0.01)and
vascular endothelial growth factor (r 
0.39, P  0.05).
Seven diabetic patients (three non-
neuropathic and four neuropathic, four
males, mean age 55  7 years) had a sec-
ond MRI spectroscopy test after an aver-
age 23-month period from the ﬁrst one.
There was a signiﬁcant decline in the
PCr/Pi ratio (0.18  0.18, P  0.05)
but no difference in the total
31P concen-
tration levels (1.1  2.32, NS).
CONCLUSIONS— The main ﬁnd-
ingsofthepresentstudyarethatthereare
signiﬁcant differences in the muscle en-
ergy reserves among all three studied
groups.Thus,thePCr/Piratiowashighest
inthecontrolgroup,followedbythenon-
neuropathicgroup,andlowestintheneu-
ropathic group. In addition, the total
31P
concentration, an indication of the mus-
cle volume, was decreased in the neuro-
pathic group but was comparable in the
control and non-neuropathic groups.
Similarly, the lipid/water ratio, an indica-
tion of muscle atrophy, was increased in
theneuropathicgroup,whereasnodiffer-
ences existed between the control and
non-neuropathic groups. Finally, muscle
changes were associated with changes in
the nerve function, endothelial function
of the large vessels, and serum cytokines.
There are limited data available re-
gardingtheeffectsofdiabetesandperiph-
eral neuropathy on muscle energy
reserves. Previous studies have shown re-
ducedenergyreservesindiabeticpatients
at skeletal muscles during resting and ex-
ercise and the myocardium (8–11). The
results of the present study indicate that
compared with healthy control subjects,
there is a stepwise reduction in the foot
muscle energy reserves in diabetic pa-
tients without peripheral neuropathy and
a more severe reduction in diabetic pa-
tients with clinical neuropathy. The main
reasonforidentifyingthisdifferenceisthe
technology we used, which has a higher
spatial resolution than previous methods,
resultinginmoreaccuratemeasurements.
Our ﬁndings also suggest that diabe-
tes and the associated endothelial dys-
function and inﬂammation have an
adverse effect on the foot muscle energy
reserves even before the development of
clinical neuropathy. However, the devel-
opment of neuropathy has a much higher
impact and leads to a considerable dete-
rioration of these abnormalities. Further
studies will be required to examine the
effect of diabetes in muscles that are not
affectedsoseverelybyperipheralneurop-
athy, such as the forearm or leg muscles.
In the present study, we have also ex-
amined the changes in MRI spectroscopic
measurements over a 23-month period
onaverage.Itisofinterestthatwenoteda
deterioration of the PCr/Pi ratio but no
changes in the total
31P concentration.
These results indicate that functional
changes can progress even in the absence
of atrophy progression over a 23-month
period. Conﬁrmation of these ﬁnding by
future studies may lead to the use of these
MRI spectroscopic measurements as sur-
rogate end points that will evaluate the
effect of new therapeutic approaches on
the muscle function of diabetic patients
with or without peripheral neuropathy
and/or ischemia.
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